UROVANT SCIENCES LTD's ticker is UROV and the CUSIP is G9381B108. A total of 25 filers reported holding UROVANT SCIENCES LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,610,000 | +93.3% | 99,876 | +11.9% | 0.00% | – |
| Q3 2020 | $833,000 | -5.1% | 89,246 | 0.0% | 0.00% | – |
| Q2 2020 | $878,000 | +15.7% | 89,246 | +8.3% | 0.00% | – |
| Q1 2020 | $759,000 | -69.3% | 82,371 | -48.3% | 0.00% | – |
| Q4 2019 | $2,470,000 | +210.7% | 159,312 | +89.7% | 0.00% | – |
| Q3 2019 | $795,000 | +18.3% | 83,962 | -1.2% | 0.00% | – |
| Q2 2019 | $672,000 | +71.9% | 84,996 | +118.3% | 0.00% | – |
| Q1 2019 | $391,000 | – | 38,943 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 157,480 | $1,246,000 | 0.82% |
| Prosight Management, LP | 142,620 | $1,128,000 | 0.57% |
| Sio Capital Management, LLC | 220,042 | $1,741,000 | 0.42% |
| Perceptive Advisors | 1,875,426 | $14,835,000 | 0.34% |
| Park West Asset Management LLC | 432,500 | $3,421,000 | 0.14% |
| Eventide Asset Management | 401,558 | $3,176,000 | 0.10% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $7,910,000 | 0.02% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 51,100 | $404,000 | 0.01% |
| Weiss Multi-Strategy Advisers LLC | 25,000 | $198,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 438,911 | $3,472,000 | 0.01% |